Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-05-02
2006-05-02
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S184000
Reexamination Certificate
active
07037909
ABSTRACT:
The present invention relates to compounds of the Formulae (I) and (II), wherein R1-R10and G are defined herein, and their pharmaceutically acceptable salts. These compounds modulate the activity of c-Met and are therefore expected to be useful in the prevention and treatment of c-Met related disorders such as cancer.
REFERENCES:
patent: 4084053 (1978-04-01), Desai et al.
patent: 4159375 (1979-06-01), Trust et al.
patent: 4405619 (1983-09-01), Heilman et al.
patent: 6410715 (1965-03-01), None
patent: WO 96/18770 (1996-06-01), None
patent: WO 97/48786 (1997-12-01), None
patent: WO 99/01607 (1999-01-01), None
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
Knudsen et al. Adv Cancer Res. 91: 31-67, 2004.
Elliott et al. Can. J. Physiol. Pharmacol. 80(2) : 91-102, 2002.
Dornow et al., “Desaminierung von 4-Amino-1.2.4-triazinen,”Chemische Berichte, Sep. 1964, pp. 2647-2651, vol. 97, No. 9.
Dornow et al., “Übert Umsetzungen von a-Chlor-oximen. II2,”Chemische Berichte, 1964, pp. 2165-2168, vol. 97, No. 8.
Labouta et al., “Synthesis of Some Substituted Triazolo[4,3-b][1,2,4]triazines as Potential Anticancer Agents,”Monatshefte für Chemie, 1988, pp. 591-596, vol. 119.
Lovell et al., “6- An 7-Aryl-1,2,4-triazolo[4,3-b]-1,2,4-triazines. Synthesis and Characterization (1),”Journal of Heterocyclic Chemistry, Nov. 1979, pp. 1393-1403, vol. 16, No. 7.
Mousaad et al., “Synthesis of 3-(Alditol-1-yl)triazolo[4′,3′:2,3]-1,2,4-triazno[5,6-b]indoles,”Bull. Chem. Soc. Jpn., 1992, pp. 546-552, vol. 65, No. 2, The Chemical Society of Japan.
Rahman, “Synthesis of Some More Heterobicyclic Derivatives Bearing A 1,2,4-Triazine Moiety and Their Antibacterial Activity,”Pakistan Journal of Scientifici and Industrial Research, Apr. 1989, pp. 240-245, vol. 32, No. 4, Pakistan Council of Scientific and Industrial Research Karachi.
Rashed et al., “10-Carbethoxymethyl-3-phenyl-1,2,4-triazolo[4′,3′:2,3][1,2,4]triazino [5,6-b]indole and Derivatives at its 10-Position,”Archiv der Pharmazie, Mar. 1993, pp. 153-156, vol. 326, No. 3, VCH.
Shaban et al., “Sterically controlled regiospecific heterocyclization of 3-hydrazino-5-methyl-1,2,4-triazino[5,6-a]indole to 10-methyl-1,2,4-triazolo[4′,3′:2,3]1,2,4-triazino[5,6-b]indoles,”II Farmaco, 1999, pp. 800-809, vol. 54, Elsevier.
Tomchin,Zhurnal Organicheskoi Kimii, 1982, pp. 1272-1280, vol. 18, No. 6.
Vlietinck, “Triazolotriazines as Potential Chemoterapeutic Agents. IV.”Journal of Heterocyclic Chemistry, Sep.-Oct. 1987, vol. 24, No. 5.
Zaher et al., “uncondensed 1,2,4-Triazines: Part I—Behaviour of 3-Hydrazino-5,6,-diphenyl-1,2,4-triazine Towards Acylating Agents, Activated Alkenes & Carbonyl Compounds,”Indian Journal of Chemistry, Oct. 1979, pp. 316-319, vol. 18B.
Cui Jingrong
Koenig Marcel
Vojkovsky Tomas
Zhang Fang-Jie
Balasubramanian Venkataraman
Liptak Vincent P.
Sugen Inc.
Zielinski Bryan C.
LandOfFree
Tetracyclic compounds as c-Met inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetracyclic compounds as c-Met inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetracyclic compounds as c-Met inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3652419